Since certain elevated levels of miRNAs and lncRNAs may also contribute to cancer promotion, more consideration should be taken in targeting of the ncRNA/PDCD4 pathway during the treatment of inflammatory diseases. The gene discussed is PDCD4; the disease is cancer.